Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2―Negative Advanced Breast Cancer That Progressed during or after Bevacizumab von SCHWARTZBERG, Lee S, TAUER, Kurt W, BELL-MCGUINN, Katherine, KIRSHNER, Jeffrey J, EISENBERG, Peter, EMANUELSON, Richard, KEATON, Mark, LEVINE, Ellis, MEDGYESY, Diana C, QAMAR, Rubina, STARR, Alexander, SUNHEE KWON RO, HERMANN, Robert C, LOKKER, Nathalie A, HUDIS, Clifford A, MAKARI-JUDSON, Grace, ISAACS, Claudine, THADDEUS BECK, J, KAKLAMANI, Virginia, STEPANSKI, Edward J, RUGO, Hope S, WEI WANG

Volltext

Abstract OT-03-03: SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer von Beckwith, Heather C, Medgyesy, Diana C, Abraham, Jame, Nanda, Rita, Tkaczuk, Katherine HR, Krop, Ian E, Pusztai, Lajos, Modi, Shanu, Mita, Monica M, Specht, Jennifer M, Hurvitz, Sara A, Han, Hyo S, Kalinsky, Kevin, Wilks, Sharon, O’Shaughnessy, Joyce, Hart, Lowell L, Rugo, Hope S, Mitri, Zahi I, Garfin, Phillip M, Burris, Howard A

Volltext

Small cell carcinoma of the esophagus : The University of Texas M. D. Anderson Cancer Center Experience and Literature Review von MEDGYESY, D. C, WOLFF, R. A, PUTNAM, J. B, AJANI, J. A

Volltext

Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hour continuous infusion weekly for three weeks in metastatic colorectal carcinoma von PAZDUR, R, MEDGYESY, D. C, WINN, R. J, DAKHIL, S. R, MOORE, D. F, SCALZO, A, HOFF, P. M, ARBUCK, S. G, ABBRUZZESE, J. L

Volltext

Small cell carcinoma of the esophagus von Medgyesy, Diana C., Wolff, Robert A., Putnam, Joe B., Ajani, Jaffer A.

Volltext

Phase I Study with Pharmacokinetics of S-1 on an Oral Daily Schedule for 28 Days in Patients with Solid Tumors von HOFF, Paulo M, SAAD, Everardo D, AJANI, Jaffer A, LASSERE, Yvonne, WENSKE, Cynthia, MEDGYESY, Diana, DWIVEDY, Sunita, RUSSO, Mark, PAZDUR, Richard

Volltext